M 6 A‐mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8 + T cells and phagocytosis of macrophages
Advanced Science · 2024-09 · 11 (34)
DOI: 10.1002/advs.202400695 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 09.07.2024. Verfasst von Qing Xi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Liver Neoplasms, CD8-Positive T-Lymphocytes, Up-Regulation. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Project funded by China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Tumor immune evasion relies on the crosstalk between tumor cells and adaptive/innate immune cells. Immune checkpoints play critical roles in the crosstalk, and immune checkpoint inhibitors have achieved promising clinical effects. The long non‐coding RNA taurine‐upregulated gene 1 (TUG1) is upregulated in hepatocellular carcinoma (HCC). However, how TUG1 is upregulated and the effects on tumor immune evasion are incompletely understood. Here, METTL3‐mediated m 6 A modification led to TUG1 upregulation is demonstrated. Knockdown of TUG1 inhibited tumor growth and metastasis, increased the infiltration of CD8 + T cells and M1‐like macrophages in tumors, promoted the activation of CD8 + T cells through PD‐L1, and improved the phagocytosis of macrophages through CD47. Mechanistically, TUG1 regulated PD‐L1 and CD47 expressions by acting as a sponge of miR‐141 and miR‐340, respectively. Meanwhile, TUG1 interacted with YBX1 to facilitate the upregulation of PD‐L1 and CD47 transcriptionally, which ultimately regulated tumor immune evasion. Clinically, TUG1 positively correlated with PD‐L1 and CD47 in HCC tissues. Moreover, the combination of Tug1‐siRNA therapy with a Pdl1 antibody effectively suppressed tumor growth. Therefore, the mechanism of TUG1 in regulating tumor immune evasion is revealed and can inform existing strategies targeting TUG1 for enhancing HCC immune therapy and drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Guangdong Pharmaceutical University, Guangzhou, 510080, China.
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou, 511442, China.
- Laboratory of Immunology and Inflammation, Department of Immunology, Key Laboratory of Immune Microenvironment and Diseases of Educational Ministry of China, Tianjin Medical University, Tianjin, 300070, China.
- Laboratory of Immunology and Inflammation, Department of Biotechnology, School of Life Sciences and Biopharmaceutics, Guangdong Provincial Key Laboratory of Advanced Drug Delivery, Guangdong Provincial Engineering Cente…
- Department of Hepatobiliopancreatic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
- Department of Bioscience, School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 51006, China.
ORCID-Profile: Rongxin Zhang
Förderung
- National Natural Science Foundation of China
- Guangdong Basic and Applied Basic Research Foundation
- Project funded by China Postdoctoral Science Foundation
- Science and Technology Development Foundation of Henan Province
- Henan Provincial Medical Science and Technology Project
Zitieren
APA
Xi, Q., Yang, G., He, X., Zhuang, H., Li, L., Lin, B., Wang, L., Wang, X., Fang, C., Chen, Q., Yang, Y., Yu, Z., Zhang, H., Cai, W., Li, Y., Shen, H., Liu, L., & Zhang, R. (2024). M 6 A‐mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8 + T cells and phagocytosis of macrophages. Advanced Science, 11(34). https://doi.org/10.1002/advs.202400695
Vancouver
Xi Q, Yang G, He X, Zhuang H, Li L, Lin B, et al. M 6 A‐mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8 + T cells and phagocytosis of macrophages. Advanced Science. 2024;11(34). doi:10.1002/advs.202400695
BibTeX
@article{Xi2024,
author = {Xi, Qing and Yang, Guangze and He, Xue and Zhuang, Hao and Li, Li and Lin, Bing and Wang, Lingling and Wang, Xianyang and Fang, Chunqiang and Chen, Qiurui and Yang, Yongjie and Yu, Zhaoan and Zhang, Hao and Cai, Wenqian and Li, Yan and Shen, Han and Liu, Li and Zhang, Rongxin},
title = {M 6 A‐mediated upregulation of lncRNA TUG1 in liver cancer cells regulates the antitumor response of CD8 + T cells and phagocytosis of macrophages},
journal = {Advanced Science},
year = {2024},
volume = {11},
number = {34},
doi = {10.1002/advs.202400695}
}
EUVIMED